These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Estrogen replacement therapy continuously combined with four different dosages of dydrogesterone: effect on calcium and lipid metabolism. Voetberg GA, Netelenbos JC, Kenemans P, Peters-Muller ER, van de Weijer PH. J Clin Endocrinol Metab; 1994 Nov; 79(5):1465-9. PubMed ID: 7962344 [Abstract] [Full Text] [Related]
8. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study. Heikkinen AM, Parviainen M, Niskanen L, Komulainen M, Tuppurainen MT, Kröger H, Saarikoski S. J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321 [Abstract] [Full Text] [Related]
10. Effect of micronized progesterone on bone turnover in postmenopausal women on estrogen replacement therapy. Azizi G, Hansen A, Prestwood KM. Endocr Res; 2003 May; 29(2):133-40. PubMed ID: 12856800 [Abstract] [Full Text] [Related]
11. Effect of the menopause and hormone replacement therapy on the carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen. Hassager C, Risteli J, Risteli L, Christiansen C. Osteoporos Int; 1994 Nov; 4(6):349-52. PubMed ID: 7696831 [Abstract] [Full Text] [Related]
12. The usefulness of biochemical bone markers in predicting the response of hormone replacement therapy in perimenopausal cigarette smoking healthy women. Cubrilo-Turek M, Stavljenić-Rukavina A, Turek S, Kusec V, Duraković Z. Coll Antropol; 1999 Jun; 23(1):195-201. PubMed ID: 10402723 [Abstract] [Full Text] [Related]